Saskia E. van Mil

1.7k total citations
17 papers, 1.2k citations indexed

About

Saskia E. van Mil is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, Saskia E. van Mil has authored 17 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 8 papers in Genetics and 5 papers in Oncology. Recurrent topics in Saskia E. van Mil's work include DNA Repair Mechanisms (7 papers), BRCA gene mutations in cancer (6 papers) and Cancer-related Molecular Pathways (4 papers). Saskia E. van Mil is often cited by papers focused on DNA Repair Mechanisms (7 papers), BRCA gene mutations in cancer (6 papers) and Cancer-related Molecular Pathways (4 papers). Saskia E. van Mil collaborates with scholars based in Netherlands, United States and United Kingdom. Saskia E. van Mil's co-authors include Peter Heutink, Douglas B. Gould, Simon W. M. John, Marjo S. van der Knaap, Umberto Aguglia, John C. Schimenti, Guido J. Breedveld, Richard S. Smith, Elisabeth Tournier‐Lasserve and John P. Sundberg and has published in prestigious journals such as Science, New England Journal of Medicine and SHILAP Revista de lepidopterología.

In The Last Decade

Saskia E. van Mil

17 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Saskia E. van Mil Netherlands 13 428 343 315 280 174 17 1.2k
Gwénola Boulday France 19 495 1.2× 708 2.1× 116 0.4× 55 0.2× 125 0.7× 30 1.5k
Cristina Roca Italy 9 1.4k 3.3× 122 0.4× 140 0.4× 97 0.3× 380 2.2× 9 2.0k
Konstantin Gaengel Sweden 14 844 2.0× 110 0.3× 73 0.2× 45 0.2× 153 0.9× 20 1.3k
P. V. Steart United Kingdom 16 517 1.2× 225 0.7× 40 0.1× 72 0.3× 137 0.8× 21 1.2k
Jan Manent United States 15 380 0.9× 358 1.0× 103 0.3× 67 0.2× 81 0.5× 21 866
Noemi Rudini Italy 14 853 2.0× 492 1.4× 86 0.3× 55 0.2× 202 1.2× 20 1.8k
Nancy A. Edwards United States 15 490 1.1× 194 0.6× 31 0.1× 84 0.3× 133 0.8× 28 1.1k
Jarkko Kortesmaa Sweden 18 664 1.6× 134 0.4× 770 2.4× 70 0.3× 179 1.0× 18 1.6k
Lisa A. Cannon United States 9 198 0.5× 368 1.1× 76 0.2× 181 0.6× 195 1.1× 14 956
Kathryn A. Grako United States 6 619 1.4× 35 0.1× 164 0.5× 92 0.3× 126 0.7× 7 1.1k

Countries citing papers authored by Saskia E. van Mil

Since Specialization
Citations

This map shows the geographic impact of Saskia E. van Mil's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Saskia E. van Mil with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Saskia E. van Mil more than expected).

Fields of papers citing papers by Saskia E. van Mil

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Saskia E. van Mil. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Saskia E. van Mil. The network helps show where Saskia E. van Mil may publish in the future.

Co-authorship network of co-authors of Saskia E. van Mil

This figure shows the co-authorship network connecting the top 25 collaborators of Saskia E. van Mil. A scholar is included among the top collaborators of Saskia E. van Mil based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Saskia E. van Mil. Saskia E. van Mil is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Jong, Yvonne de, et al.. (2022). High-Level MYCN-Amplified RB1-Proficient Retinoblastoma Tumors Retain Distinct Molecular Signatures. SHILAP Revista de lepidopterología. 2(3). 100188–100188. 12 indexed citations
2.
Vrugt, Henri J. van de, Joey Riepsaame, Saskia E. van Mil, et al.. (2019). Effective CRISPR/Cas9-mediated correction of a Fanconi anemia defect by error-prone end joining or templated repair. Scientific Reports. 9(1). 768–768. 20 indexed citations
3.
Kooi, Irsan, Berber M. Mol, Maarten P.G. Massink, et al.. (2016). Somatic genomic alterations in retinoblastoma beyond RB1 are rare and limited to copy number changes. Scientific Reports. 6(1). 25264–25264. 74 indexed citations
4.
Kooi, Irsan, Saskia E. van Mil, David MacPherson, et al.. (2016). Genomic landscape of retinoblastoma in Rb−/−p130−/− mice resembles human retinoblastoma. Genes Chromosomes and Cancer. 56(3). 231–242. 5 indexed citations
5.
Stoepker, Chantal, Najim Ameziane, Petra van der Lelij, et al.. (2015). Defects in the Fanconi Anemia Pathway and Chromatid Cohesion in Head and Neck Cancer. Cancer Research. 75(17). 3543–3553. 25 indexed citations
6.
Kooi, Irsan, Berber M. Mol, Annette C. Moll, et al.. (2015). Loss of photoreceptorness and gain of genomic alterations in retinoblastoma reveal tumor progression. EBioMedicine. 2(7). 660–670. 49 indexed citations
7.
Stoepker, Chantal, Martin A. Rooimans, Saskia E. van Mil, et al.. (2014). DNA helicases FANCM and DDX11 are determinants of PARP inhibitor sensitivity. DNA repair. 26. 54–64. 28 indexed citations
8.
Thirthagiri, Eswary, Saskia E. van Mil, Muriel A. Adank, et al.. (2014). A Novel Splice Site Mutation in the Noncoding Region ofBRCA2: Implications for Fanconi Anemia and Familial Breast Cancer Diagnostics. Human Mutation. 35(4). 442–446. 7 indexed citations
9.
Mil, Saskia E. van, Gerry P. Crossan, Nelly Sabbaghian, et al.. (2012). Analysis of the Novel Fanconi Anemia GeneSLX4/FANCPin Familial Breast Cancer Cases. Human Mutation. 34(1). 70–73. 15 indexed citations
10.
Harinck, Femme, Irma Kluijt, Saskia E. van Mil, et al.. (2011). Routine testing for PALB2 mutations in familial pancreatic cancer families and breast cancer families with pancreatic cancer is not indicated. European Journal of Human Genetics. 20(5). 577–579. 28 indexed citations
11.
Adank, Muriel A., Marianne A. Jonker, Irma Kluijt, et al.. (2011). CHEK2*1100delC homozygosity is associated with a high breast cancer risk in women. Journal of Medical Genetics. 48(12). 860–863. 53 indexed citations
12.
Adank, Muriel A., Heidi Segers, Saskia E. van Mil, et al.. (2010). Fanconi anemia gene mutations are not involved in sporadic Wilms tumor. Pediatric Blood & Cancer. 55(4). 742–744. 3 indexed citations
13.
Adank, Muriel A., Saskia E. van Mil, Gilles Thomas, Quinten Waisfisz, & Hanne Meijers-Heijboer. (2010). PALB2 analysis in BRCA2-like families. Breast Cancer Research and Treatment. 127(2). 357–362. 39 indexed citations
14.
Bronner, Iraad F., Patrizia Rizzu, Harro Seelaar, et al.. (2007). Progranulin mutations in Dutch familial frontotemporal lobar degeneration. European Journal of Human Genetics. 15(3). 369–374. 47 indexed citations
15.
Gould, Douglas B., Saskia E. van Mil, John P. Sundberg, et al.. (2006). Role of COL4A1 in Small-Vessel Disease and Hemorrhagic Stroke. New England Journal of Medicine. 354(14). 1489–1496. 388 indexed citations
16.
Rizzu, Patrizia, Saskia E. van Mil, Burcu Anar, et al.. (2006). CHMP2B mutations are not a cause of dementia in Dutch patients with familial and sporadic frontotemporal dementia. American Journal of Medical Genetics Part B Neuropsychiatric Genetics. 141B(8). 944–946. 33 indexed citations
17.
Gould, Douglas B., Guido J. Breedveld, Saskia E. van Mil, et al.. (2005). Mutations in Col4a1 Cause Perinatal Cerebral Hemorrhage and Porencephaly. Science. 308(5725). 1167–1171. 366 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gwénola Boulday Breakdown of academic impact, for papers by Cristina Roca Breakdown of academic impact, for papers by Konstantin Gaengel Breakdown of academic impact, for papers by P. V. Steart Breakdown of academic impact, for papers by Jan Manent Breakdown of academic impact, for papers by Noemi Rudini Breakdown of academic impact, for papers by Nancy A. Edwards Breakdown of academic impact, for papers by Jarkko Kortesmaa Breakdown of academic impact, for papers by Lisa A. Cannon Breakdown of academic impact, for papers by Kathryn A. Grako
Rankless by CCL
2026